A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 65,842 shares of CRSP stock, worth $3.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
65,842
Previous 77,018 14.51%
Holding current value
$3.05 Million
Previous $4.16 Million 25.63%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$44.62 - $62.75 $498,673 - $701,294
-11,176 Reduced 14.51%
65,842 $3.09 Million
Q2 2024

Aug 14, 2024

BUY
$51.17 - $68.18 $3.94 Million - $5.25 Million
77,018 New
77,018 $4.16 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.